G24.02 Drug induced acute dystonia

Name of the Condition

• Drug induced acute dystonia (ICD-10 Code: G24.02)

Summary

Drug induced acute dystonia is a movement disorder characterized by sudden, involuntary muscle contractions and abnormal postures resulting from exposure to certain medications. These movements typically develop within hours to days of initiating or adjusting the drug and may affect specific body regions, such as the face, neck, or limbs. The condition is generally reversible with appropriate intervention.

Causes

Drug induced acute dystonia is caused by adverse reactions to medications, most commonly dopamine receptor antagonists such as antipsychotics (e.g., typical and atypical neuroleptics) and antiemetics (e.g., metoclopramide). The mechanism involves disruption of dopamine signaling in the basal ganglia, leading to abnormal muscle tone and movement.

Risk Factors

• Use of dopamine receptor antagonists, including antipsychotics and antiemetics.
• High doses or rapid titration of these medications.
• Individual susceptibility, such as younger age or genetic predisposition.

Symptoms

• Involuntary muscle spasms or contractions.
• Abnormal postures (e.g., torticollis, opisthotonus, or limb dystonia).
• Repetitive twisting movements.
• Pain or discomfort in affected areas.
• Difficulty with voluntary movements (e.g., speaking, swallowing, or walking).

Diagnosis

Diagnosis is based on a temporal relationship between medication exposure and symptom onset, along with clinical evaluation of movement patterns. A thorough medication history is essential to identify the causative agent. Neurological examination confirms the presence of dystonic movements, and other conditions are ruled out through clinical assessment.

Treatment Options

Treatment involves discontinuing or adjusting the offending medication. Acute management may include anticholinergic agents (e.g., benztropine) or antihistamines (e.g., diphenhydramine) to relieve symptoms. Supportive care, such as hydration and monitoring, is also provided.

Prognosis and Follow-Up

With prompt intervention, symptoms typically resolve within hours to days. Follow-up ensures resolution of symptoms and adjustment of future medication regimens to prevent recurrence. Long-term prognosis is favorable if the causative drug is avoided.

Complications

• Respiratory distress if neck or throat muscles are affected.
• Injury from falls or abnormal postures.
• Psychological distress due to visible symptoms.

Lifestyle & Prevention

• Avoidance of high-risk medications when possible.
• Gradual titration of dopamine receptor antagonists.
• Patient education on early symptom recognition.

When to Seek Professional Help

Seek immediate medical attention if dystonic movements are severe, affect breathing or swallowing, or cause significant pain or distress.

Tips for Medical Coders

Document the specific medication implicated, onset timing (acute), and affected body regions. Ensure the code G24.02 is used when the dystonia is drug-induced and acute in nature, with clear clinical correlation to medication exposure.